|
|
Blood, 15 February 2005, Vol. 105, No. 4, pp. 1484-1491.
Prepublished online as a Blood First Edition Paper on October 28, 2004; DOI 10.1182/blood-2004-07-2856.
Previous Article | Table of Contents | Next Article 
HEMATOPOIESIS
Normal hematopoiesis is maintained by activated bone marrow CD4+ T cells
João P. Monteiro,
Aline Benjamin,
Elaine S. Costa,
Marcello A. Barcinski, and
Adriana Bonomo
From the Divisão de Medicina Experimental, Coordenação de Pesquisa, Instituto Nacional de Câncer, Brazil; Departamento de Histologia e Embriologia, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Brazil; Instituto de Pediatria e Puericultura Martagão Gesteira, Universidade Federal do Rio de Janeiro, Brazil; Departamento de Parasitologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, Brazil; Departamento de Imunologia, Centro de Ciências da Saúde, Universidade Federal do Rio de Janeiro, Brazil.
CD4+ T cells produce hematopoietic-related cytokines and are essential for hematopoiesis stimulation during infection and hematologic recovery after bone marrow transplantation. However, it remains unclear if T cells are necessary to maintain normal hematopoiesis. We report here that, in T-celldeficient mice, terminal differentiation of myeloid progenitors is defective, resulting in very low levels of granulocytes in the periphery. Hematopoiesis is restored after thymus graft or reconstitution with CD4+ T cells but not CD8+ T cells. Bone marrow CD4+ T cells have an activated phenotype and produce cytokines, apparently, in the absence of exogenous stimulation. Transgenic mice carrying T-cell receptor specific for an ovalbumin peptide presented in the context of a specific class II molecule (I-Ad) (DO11.10 RAG/) show the same hematopoietic deficiency as athymic mice. Their bone marrow CD4+ T cells are not activated, suggesting that hematopoiesis maintenance requires the presence of cognate antigen in order to activate bone marrow T-helper cells. In fact, priming of transgenic mice with ovalbumin restores normal hematopoiesis. The data show that the current concept of "normal hematopoiesis" does not reflect a basal bone marrow activity, but it is an antigen-induced state maintained by constant activation of bone marrow CD4+ T cells.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. Shen, S. Kim, J.-s. Do, L. Wang, C. Lantz, J. F. Urban, G. Le Gros, and B. Min
T cell-derived IL-3 plays key role in parasite infection-induced basophil production but is dispensable for in vivo basophil survival
Int. Immunol.,
July 15, 2008;
(2008)
dxn077v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Movahedi, M. Guilliams, J. Van den Bossche, R. Van den Bergh, C. Gysemans, A. Beschin, P. De Baetselier, and J. A. Van Ginderachter
Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity
Blood,
April 15, 2008;
111(8):
4233 - 4244.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Li, N. Perez, S. Karumuthil-Melethil, and C. Vasu
Bone Marrow Is a Preferential Homing Site for Autoreactive T-Cells in Type 1 Diabetes
Diabetes,
September 1, 2007;
56(9):
2251 - 2259.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Lan, N. Tonomura, A. Shimizu, S. Wang, and Y.-G. Yang
Reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus/liver and CD34+ cell transplantation
Blood,
July 15, 2006;
108(2):
487 - 492.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Tan, W. Huang, Q. Zhong, and P. Schwarzenberger
IL-17 Receptor Knockout Mice Have Enhanced Myelotoxicity and Impaired Hemopoietic Recovery Following Gamma Irradiation
J. Immunol.,
May 15, 2006;
176(10):
6186 - 6193.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Kotsianidis, J. D. Silk, E. Spanoudakis, S. Patterson, A. Almeida, R. R. Schmidt, C. Tsatalas, G. Bourikas, V. Cerundolo, I. A. G. Roberts, et al.
Regulation of hematopoiesis in vitro and in vivo by invariant NKT cells
Blood,
April 15, 2006;
107(8):
3138 - 3144.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. F. M. Vasconcelos, B. M. dos Santos, J. Farache, T. S. S. Palmeira, R. B. Areal, J. M. T. Cunha, M. A. Barcinski, and A. Bonomo
G-CSF-treated granulocytes inhibit acute graft-versus-host disease
Blood,
March 1, 2006;
107(5):
2192 - 2199.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |